Orbital anastomoses of the anterior deep temporal artery

The anterior deep temporal artery may provide a major collateral pathway to the intracranial circulation through anastomoses with branches of the ophthalmic artery. Review of carotid angiograms in 26 patients with internal carotid artery occlusive disease revealed anterior deep temporal to ophthalmic artery anastomoses in 16 cases. This route of collateral blood flow was associated in most instances with total occlusion of the cervical portion of the internal carotid artery. Three cases demonstrating the angiographic anatomy of the anterior deep temporal artery and its potential anastomoses with branches of the ophthalmic artery are presented. L'artère temporale profonde antérieure peut être à l'origine de circulation colatérale grâce à ses anastomoses avec l'artère ophtalmique. Une telle anastomose a été constatée 16 fois sur 26 cas de thrombose de l'artère carotide interne. Über die A. temporalis anterior ist über Anastomosen zu den Ästen der A. ophthalmica ein Kollateral-Kreislauf zu den intracraniellen Gefäßabschnitten möglich. Bei 26 Patienten mit einem A. carotis interna-Verschluß zeigte sich dieser Kreislauf in 16 Fällen. Es wird über 3 Fälle ausführlich berichtet, bei denen die angiographische Anatomie der A. temporalis anterior und die möglichen Anastomosen mit Ästen der A. ophthalmica besprochen wird.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/46672/1/234_2004_Article_BF00335020.pd

Programmed delivery of verapamil hydrochloride from tablet in a capsule device

The aim of the present work was to develop a programmed drug delivery system which would be able to release the drug after 6 h of lag time by use of hydrophilic polymers. The capsule body was made impermeable by use of formaldehyde vapor treatment, while the cap was untreated. The capsule was filled with two layered tablets (tablet-in-capsule), followed by a sodium bicarbonate:citric acid mixture (SBCM) and lactose as bulking agent. Sodium alginate, chitosan, HPMC K15 and chitosan:sodium alginate complex (CSAC) were used as the rate modulating layer. Through combined use of HPMC K15 and adjusting the ratio of CSAC, the desired lag time of 6 h was obtained. The effect of the bulking agents on the lag time were also studied and it was found that the lag time was decreased with higher amounts of lactose, and delayed dissolution and decreased lag time was observed at higher amount of effervescent mixture.O objetivo do presente trabalho foi desenvolver sistema de liberação programada de cloridrato de verapamil capaz de liberação imediata do fármaco após 6 h de intervalo de tempo usando polímeros hidrofílicos. O corpo da cápsula foi impermeabilizado por tratamento de vapor de formaldeído, enquanto a tampa não foi submetida ao tratamento. Dois comprimidos foram inseridos na cápsula (comprimidos em cápsula) seguido de mistura de bicarbonato de sódio: ácido cítrico e lactose, utilizados como excipientes. O alginato de sódio, a quitosana, o HPMC K15 e o complexo quitosana:alginato de sódio foram utilizados para modular a razão de liberação do fármaco. A combinação entre o HPMC K15 e o ajuste da proporção do complexo quitosana:alginato de sódio permitiu a liberação do fármaco após 6 h. O efeito dos excipientes na liberação do fármaco foi também avaliado. Verificou-se que o tempo de latência foi reduzido na presença de maior quantidade de lactose, enquanto o menor tempo foi observado empregando maior concentração da mistura efervescente